Skip to content
Monday, May 23, 2022
Latest:
  • TikTok Benadryl Challenge
  • The full list of hand sanitizers to avoid
  • FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
  • Is acetaminophen a carcinogen?
  • Belviq and risk of cancer linked

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

  • Home
  • FDA Recalls
  • Drug Recalls
  • Current Lawsuits
  • Contact

Olmesartan

FDA Advisory 

Blood pressure medications linked to increased risk of cancer

June 12, 2010June 14, 2010 Amias, angiotensin-receptor, Aprovel, ARB, Atacand, Avapro, Benicar, Blood pressure, Blopress, Candesartan, Cozaar, Diovan, Irbesartan, Karvea, Losartan, Micardis, Novartis, Olmesartan, Olmetec, Ratacand, Telmisartan, Valsartan

According to a study published in the British medical journal The Lancet Oncology, certain blood pressure medications may be linked to

Read more

Recent Posts

  • TikTok Benadryl Challenge
  • The full list of hand sanitizers to avoid
  • FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
  • Is acetaminophen a carcinogen?
  • Belviq and risk of cancer linked

Categories

Useful Links

  • DailyMed – marketed drugs
  • FDA Drug Recalls
  • MedlinePlus Drugs Information
  • Pillbox – Pill identification
  • Terms of use
  • About
  • Contact
Copyright © 2022 Faulty Drugs. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.